{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:43:44Z","timestamp":1787071424862,"version":"build-2736575974"},"reference-count":120,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Irritable bowel syndrome (IBS) is a prevalent, chronic functional gastrointestinal disorder that significantly impairs patients\u2019 quality of life. To promote standardized and high-quality care, the Saudi Neurogastroenterology and Motility Group, under the auspices of Saudi Gastroenterology Association (SGA) and in collaboration with the European Society of Neurogastroenterology and Motility (ESNM), developed evidence based clinical practice guidelines for the diagnosis and management of IBS in Saudi Arabia. Using a modified Delphi methodology, consensus was reached when at least 80% of participants agreed with a statement as \u201ccompletely accepted\u201d or \u201caccepted with minor reservations.\u201d This process resulted in 29 consensus statements and two clinical algorithms addressing diagnostic criteria, clinical assessment, investigations, lifestyle modifications, and therapeutic strategies. The resulting guidelines provide a comprehensive framework for IBS diagnosis and management, highlight emerging treatment options, and outline areas requiring further research to enhance patient outcomes and guide future clinical practice.<\/jats:p>","DOI":"10.4103\/sjg.sjg_472_25","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:00:17Z","timestamp":1775660417000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Saudi consensus statements on the management of irritable bowel syndrome"],"prefix":"10.4103","author":[{"given":"Mohammed A.","family":"Alzahrani","sequence":"first","affiliation":[{"name":"Department of Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed R.","family":"Alzubide","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, King Saud Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Abufarhaneh","sequence":"additional","affiliation":[{"name":"Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Alqaraawi","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem A.","family":"Alamro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muslih","family":"Alhalafi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Security Forces Hospital Program, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrhman","family":"Alamr","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, King Fahd Specialist Hospital, Buraydah, Al-Qassim, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alsulaimi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, King Saud Hospital, Unaizah, Qassim, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed R.","family":"Alshumrani","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology, Department of Medicine, College of Medicine, King Saud Bin Abdulaziz University for Health Science, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem M.","family":"Alotaibi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, King Abdullah Medical City, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Marasco","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas M.","family":"Balsiger","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kantonsspital Baselland, Liestal, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alsohaibani","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pohl","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid A.","family":"Almadi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, College of Medicine, King Saud University Medical City, Riyadh, Saudi Arabia"},{"name":"McGill University Health Center, Montreal General Hospital, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"R1-20260409","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jcag\/gwy071","article-title":"Canadian association of gastroenterology clinical practice guideline for the management of irritable bowel syndrome (IBS)","volume":"2","author":"Moayyedi","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"key":"R2-20260409","doi-asserted-by":"crossref","first-page":"1624242","DOI":"10.3389\/fmed.2025.1624242","article-title":"Pathophysiological mechanisms of functional dyspepsia:A narrative review","volume":"12","author":"Wang","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R3-20260409","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","article-title":"British society of gastroenterology guidelines on the management of irritable bowel syndrome","volume":"70","author":"Vasant","year":"2021","journal-title":"Gut"},{"key":"R4-20260409","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.014","article-title":"Rome IV diagnostic questionnaires and tables for investigators and clinicians","author":"Palsson","year":"2016","journal-title":"Gastroenterology"},{"key":"R5-20260409","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.gastro.2019.07.004","article-title":"AGA clinical practice guidelines on the laboratory evaluation of functional diarrhea and diarrhea-Predominant irritable bowel syndrome in adults (IBS-D)","volume":"157","author":"Smalley","year":"2019","journal-title":"Gastroenterology"},{"key":"R6-20260409","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1053\/j.gastro.2021.12.248","article-title":"AGA clinical practice update on the role of diet in irritable bowel syndrome:Expert review","volume":"162","author":"Chey","year":"2022","journal-title":"Gastroenterology"},{"key":"R7-20260409","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5056\/jnm16214","article-title":"What is new in Rome IV","volume":"23","author":"Schmulson","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"R8-20260409","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/17474124.2023.2223975","article-title":"Irritable bowel syndrome-controversies in diagnosis and management","volume":"17","author":"Duncanson","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R9-20260409","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-functional GI disorders:Disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"R10-20260409","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders:History, pathophysiology, clinical features and Rome IV","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"R11-20260409","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R12-20260409","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome:A clinical review","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"key":"R13-20260409","first-page":"81","article-title":"Irritable bowel syndrome","volume":"166","author":"Sultan","year":"2017","journal-title":"Ann Intern Med"},{"key":"R14-20260409","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2022.04.016","article-title":"AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with constipation","volume":"163","author":"Chang","year":"2022","journal-title":"Gastroenterology"},{"key":"R15-20260409","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/S0016-5085(22)00537-6","article-title":"Spotlight:IBS treatment","volume":"163","author":"Chang","year":"2022","journal-title":"Gastroenterology"},{"key":"R16-20260409","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome:A meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R17-20260409","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(97)05276-8","article-title":"Irritable bowel syndrome","volume":"350","author":"Maxwell","year":"1997","journal-title":"Lancet"},{"key":"R18-20260409","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/gut.43.6.770","article-title":"Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper responsiveness in the general population","volume":"43","author":"Kennedy","year":"1998","journal-title":"Gut"},{"key":"R19-20260409","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"R20-20260409","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.52768\/EpidemiolPublicHealth\/1034","article-title":"Epidemiology of irritable bowel syndrome:A systematic review and meta-analysis","volume":"2","author":"Li","year":"2024","journal-title":"Epidemiol Public Health"},{"key":"R21-20260409","first-page":"e57493","article-title":"Prevalence and associated risk factors of irritable bowel syndrome among general population:A cross-sectional study in Qassim Region, Saudi Arabia","volume":"16","author":"Almuzaini","year":"2024","journal-title":"Cureus"},{"key":"R22-20260409","first-page":"e39568","article-title":"Irritable bowel syndrome:Prevalence and determinants among adults in the Makkah Region, Saudi Arabia","volume":"15","author":"Hafiz","year":"2023","journal-title":"Cureus"},{"key":"R23-20260409","first-page":"e15979","article-title":"Irritable bowel syndrome:Prevalence and risk factors in Jazan Region, Saudi Arabia","volume":"13","author":"Arishi","year":"2021","journal-title":"Cureus"},{"key":"R24-20260409","first-page":"e48639","article-title":"Prevalence and risk factors of irritable bowel syndrome among adults in Al-Qunfudah Governorate, Saudi Arabia","volume":"15","author":"Alkalash","year":"2023","journal-title":"Cureus"},{"key":"R25-20260409","first-page":"e45357","article-title":"Prevalence of irritable bowel syndrome in Saudi Arabia:A systematic review and meta-analysis","volume":"15","author":"Almasary","year":"2023","journal-title":"Cureus"},{"key":"R26-20260409","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/ijpvm.IJPVM_486_20","article-title":"The prevalence and risk factors of irritable bowel syndrome in Saudi Arabia in 2019","volume":"13","author":"Alqahtani","year":"2022","journal-title":"Int J Prev Med"},{"key":"R27-20260409","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12916-025-03930-5","article-title":"Risk factors for developing irritable bowel syndrome:systematic umbrella review of reviews","volume":"23","author":"Sulaimi","year":"2025","journal-title":"BMC Med"},{"key":"R28-20260409","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4236\/health.2019.113025","article-title":"Irritable bowel syndrome and dietary habits in northern Saudi Arabia","volume":"11","author":"Alharbi","year":"2019","journal-title":"Health"},{"key":"R29-20260409","doi-asserted-by":"crossref","first-page":"e14707","DOI":"10.1111\/nmo.14707","article-title":"The impact of running on gastrointestinal symptoms in patients with irritable bowel syndrome","volume":"36","author":"Baart","year":"2024","journal-title":"Neurogastroenterol Motil"},{"key":"R30-20260409","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.3748\/wjg.15.3591","article-title":"Post-infectious irritable bowel syndrome","volume":"15","author":"Thabane","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R31-20260409","first-page":"e32705","article-title":"The prevalence of irritable bowel syndrome and its relation to psychiatric disorders among citizens of Makkah Region, Saudi Arabia","volume":"14","author":"Alharbi","year":"2022","journal-title":"Cureus"},{"key":"R32-20260409","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12916-025-03930-5","article-title":"Risk factors for developing irritable bowel syndrome:Systematic umbrella review of reviews","volume":"23","author":"Sulaimi","year":"2025","journal-title":"BMC Med"},{"key":"R33-20260409","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5217\/ir.2023.00199","article-title":"Diagnostic strategy of irritable bowel syndrome:A low- and middle-income country perspective","volume":"22","author":"Hidayat","year":"2024","journal-title":"Intest Res"},{"key":"R34-20260409","doi-asserted-by":"crossref","DOI":"10.1080\/17474124.2025.2455586","article-title":"An evidence-based update on the diagnosis and management of irritable bowel syndrome","author":"Black","year":"2025","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R35-20260409","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/0037-5675.354224","article-title":"Irritable bowel syndrome:An approach for primary care physicians","volume":"63","author":"Tan","year":"2022","journal-title":"Singapore Med J"},{"key":"R37-20260409","doi-asserted-by":"crossref","first-page":"458","DOI":"10.14309\/ajg.0000000000001122","article-title":"ACG clinical guidelines:Colorectal cancer screening 2021","volume":"116","author":"Shaukat","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R38-20260409","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","article-title":"Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG)","volume":"69","author":"Monahan","year":"2020","journal-title":"Gut"},{"key":"R39-20260409","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(01)06581-3","article-title":"Association of adult coeliac disease with irritable bowel syndrome:A case-control study in patients fulfilling ROME II criteria referred to secondary care","volume":"358","author":"Sanders","year":"2001","journal-title":"Lancet"},{"key":"R40-20260409","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2016.466","article-title":"Screening for celiac disease in irritable bowel syndrome:An updated systematic review and meta-analysis","volume":"112","author":"Irvine","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R41-20260409","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.sjbs.2015.04.015","article-title":"Screening of coeliac disease in undetected adults and patients diagnosed with irritable bowel syndrome in Riyadh, Saudi Arabia","volume":"23","author":"Al-Ajlan","year":"2016","journal-title":"Saudi J Biol Sci"},{"key":"R42-20260409","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.3390\/ijms26051996","article-title":"The role of calprotectin in the diagnosis and treatment of inflammatory bowel disease","volume":"26","author":"Wang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R43-20260409","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1053\/j.gastro.2019.06.014","article-title":"AGA technical review on the evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D)","volume":"157","author":"Carrasco-Labra","year":"2019","journal-title":"Gastroenterology"},{"key":"R44-20260409","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2015.6","article-title":"A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS","volume":"110","author":"Menees","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R45-20260409","doi-asserted-by":"crossref","first-page":"609279","DOI":"10.3389\/fped.2020.609279","article-title":"Fecal calprotectin in combination with standard blood tests in the diagnosis of inflammatory bowel disease in children","volume":"8","author":"Ho","year":"2021","journal-title":"Front Pediatr"},{"key":"R46-20260409","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline:Management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R47-20260409","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/flgastro-2013-100426","article-title":"Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic","volume":"5","author":"Shivaji","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"R48-20260409","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/gutjnl-2017-315909","article-title":"Guidelines for the investigation of chronic diarrhoea in adults:British Society of Gastroenterology, 3rd edition","volume":"67","author":"Arasaradnam","year":"2018","journal-title":"Gut"},{"key":"R49-20260409","doi-asserted-by":"crossref","first-page":"e14481","DOI":"10.1111\/nmo.14481","article-title":"Diagnostic yield of colonoscopy for organic disease in irritable bowel syndrome and its risk factors:A meta-analysis","volume":"35","author":"Wu","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"R50-20260409","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ajg.2013.105","article-title":"Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life","volume":"108","author":"B\u00f6hn","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"(2 Suppl 2)","key":"R51-20260409","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.jaci.2009.08.028","article-title":"Food allergy","volume":"125","author":"Sischerer","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R52-20260409","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jaci.2007.05.026","article-title":"The prevalence of food allergy:A meta-analysis","volume":"120","author":"Rona","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R53-20260409","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12984","article-title":"Review article:The diagnosis and management of food allergy and food intolerances","volume":"41","author":"Turnbull","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R54-20260409","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12291-014-0426-4","article-title":"Hydrogen breath tests in gastrointestinal diseases","volume":"29","author":"Rana","year":"2014","journal-title":"Indian J Clin Biochem"},{"key":"R55-20260409","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2020.06.090","article-title":"AGA clinical practice update on small intestinal bacterial overgrowth:Expert review","volume":"159","author":"Quigley","year":"2020","journal-title":"Gastroenterology"},{"key":"R56-20260409","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/gut.2006.108712","article-title":"Small intestinal bacterial overgrowth in patients with irritable bowel syndrome","volume":"56","author":"Posserud","year":"2007","journal-title":"Gut"},{"key":"R57-20260409","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1365-2982.2010.01503.x","article-title":"Relationships between pelvic floor symptoms and function in irritable bowel syndrome","volume":"22","author":"Prott","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"R58-20260409","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12664-019-00953-8","article-title":"Clinical and anorectal manometry profile of patients with functional constipation and constipation-predominant irritable bowel syndrome","volume":"38","author":"Goyal","year":"2019","journal-title":"Indian J Gastroenterol"},{"key":"R59-20260409","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1053\/j.gastro.2018.11.069","article-title":"Current practice in the diagnosis of bile acid diarrhea","volume":"156","author":"Vijayvargiya","year":"2019","journal-title":"Gastroenterology"},{"key":"R60-20260409","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7861\/clinmedicine.10-2-124","article-title":"Bile acid malabsoption:A forgotten diagnosis?","volume":"10","author":"Khalid","year":"2010","journal-title":"Clin Med (Lond)"},{"key":"R61-20260409","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.cgh.2025.02.031","article-title":"Simplifying diagnosis of bile acid diarrhea with clinical and biochemical measurements on blood and single stool sample","volume":"23","author":"Dilmaghani","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R62-20260409","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13227","article-title":"Systematic review with meta-analysis:The prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea","volume":"42","author":"Slattery","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R63-20260409","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/gutjnl-2023-331833","article-title":"Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target","volume":"73","author":"Ford","year":"2024","journal-title":"Gut"},{"key":"R64-20260409","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jhn.12385","article-title":"British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update)","volume":"29","author":"McKenzie","year":"2016","journal-title":"J Hum Nutr Diet"},{"key":"R65-20260409","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.3748\/wjg.v21.i29.8952","article-title":"Effects of cereal fiber on bowel function:A systematic review of intervention trials","volume":"21","author":"de","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R66-20260409","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/nu10030275","article-title":"Gastrointestinal transit time, glucose homeostasis and metabolic health:Modulation by dietary fibers","volume":"10","author":"M\u00fcller","year":"2018","journal-title":"Nutrients"},{"key":"R67-20260409","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/ajg.2014.195","article-title":"The effect of fiber supplementation on irritable bowel syndrome:A systematic review and meta-analysis","volume":"109","author":"Moayyedi","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R68-20260409","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/apt.15818","article-title":"Review article:FODMAPS, prebiotics and gut health-the FODMAP hypothesis revisited","volume":"52","author":"Gibson","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R69-20260409","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5056\/jnm22035","article-title":"How to implement the 3-phase FODMAP diet into gastroenterological practice","volume":"28","author":"Sultan","year":"2022","journal-title":"J Neurogastroenterol Motil"},{"key":"R70-20260409","doi-asserted-by":"crossref","first-page":"16382","DOI":"10.1038\/s41598-025-01163-3","article-title":"The effect of low-FODMAP diet on patients with irritable bowel syndrome","volume":"15","author":"Alrasheedi","year":"2025","journal-title":"Sci Rep"},{"key":"R71-20260409","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S0029665120006990","article-title":"Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation","volume":"80","author":"Wilson","year":"2021","journal-title":"Proc Nutr Soc"},{"key":"R72-20260409","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MEG.0000000000001317","article-title":"Adherence with a low-FODMAP diet in irritable bowel syndrome:Are eating disorders the missing link?","volume":"31","author":"Mari","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R73-20260409","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41395-018-0195-4","article-title":"A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome","volume":"113","author":"Dionne","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R74-20260409","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.cgh.2022.02.045","article-title":"Efficacy and acceptability of dietary therapies in non-constipated irritable bowel syndrome:A randomized trial of traditional dietary advice, the low FODMAP diet, and the gluten-free diet","volume":"20","author":"Rej","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R75-20260409","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2468-1253(24)00045-1","article-title":"A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS):A single-centre, single-blind, randomised controlled trial","volume":"9","author":"Nybacka","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R76-20260409","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S2468-1253(25)00090-1","article-title":"Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome:A single-centre, randomised, double-blind, sham-controlled crossover trial","volume":"10","author":"Seiler","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R77-20260409","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R78-20260409","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","article-title":"Lactobacillus and bifidobacterium in irritable bowel syndrome:Symptom responses and relationship to cytokine profiles","volume":"128","author":"O'Mahony","year":"2005","journal-title":"Gastroenterology"},{"key":"R79-20260409","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2023.07.018","article-title":"Efficacy of probiotics in irritable bowel syndrome:Systematic review and meta-analysis","volume":"165","author":"Goodoory","year":"2023","journal-title":"Gastroenterology"},{"key":"R80-20260409","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1463-1318.2009.01990.x","article-title":"A randomized, double-blind, placebo-controlled trial of polyethylene glycol effects on fasting and postprandial rectal sensitivity and symptoms in hypersensitive constipation-predominant irritable bowel syndrome","volume":"12","author":"Awad","year":"2010","journal-title":"Colorectal Dis"},{"key":"R81-20260409","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/ajg.2013.197","article-title":"Randomized clinical trial:Macrogol\/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome","volume":"108","author":"Chapman","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R82-20260409","article-title":"Bowel disorders","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"R83-20260409","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2036.2008.03881.x","article-title":"Clinical trial:Lubiprostone in patients with constipation-associated irritable bowel syndrome--Results of two randomized, placebo-controlled studies","volume":"29","author":"Drossman","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R84-20260409","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/ajg.2012.255","article-title":"A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation","volume":"107","author":"Rao","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R85-20260409","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/ajg.2012.254","article-title":"Linaclotide for irritable bowel syndrome with constipation:A 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety","volume":"107","author":"Chey","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R86-20260409","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41395-018-0026-7","article-title":"Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation:Results of two phase 3 randomized clinical trials","volume":"113","author":"Brenner","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R87-20260409","doi-asserted-by":"crossref","first-page":"281","DOI":"10.14309\/ajg.0000000000000516","article-title":"Efficacy of tenapanor in treating patients with irritable bowel syndrome with constipation:A 12-week, placebo-controlled phase 3 trial (T3MPO\u20131)","volume":"115","author":"Chey","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R88-20260409","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1053\/j.gastro.2018.08.021","article-title":"Efficacy of secretagogues in patients with irritable bowel syndrome with constipation:Systematic review and network meta-analysis","volume":"155","author":"Black","year":"2018","journal-title":"Gastroenterology"},{"key":"R89-20260409","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365528709091003","article-title":"Loperamide in treatment of irritable bowel syndrome\u2014A double-blind placebo controlled study","volume":"130","author":"Lav\u00f6","year":"1987","journal-title":"Scand J Gastroenterol Suppl"},{"key":"R90-20260409","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00365528709091004","article-title":"Loperamide treatment of the irritable bowel syndrome","volume":"130","author":"Hovdenak","year":"1987","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"(Suppl 2)","key":"R91-20260409","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of gastroenterology monograph on management of irritable bowel syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R92-20260409","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1476-5381.2012.02068.x","article-title":"Modulation of gastrointestinal function by MuDelta, a mixed ? opioid receptor agonist\/? opioid receptor antagonist","volume":"167","author":"Wade","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R93-20260409","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1505180","article-title":"Eluxadoline for irritable bowel syndrome with diarrhea","volume":"374","author":"Lembo","year":"2016","journal-title":"N Engl J Med"},{"key":"R94-20260409","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome","volume":"130","author":"Atkinson","year":"2006","journal-title":"Gastroenterology"},{"key":"R95-20260409","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1572-0241.2006.00459.x","article-title":"Incidence of ischemic colitis and serious complications of constipation among patients using alosetron:Systematic review of clinical trials and post-marketing surveillance data","volume":"101","author":"Chang","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R96-20260409","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/03007995.2018.1533456","article-title":"Alosetron versus traditional pharmacotherapy in clinical practice:Effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome","volume":"35","author":"Olden","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"R97-20260409","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/ajg.2009.223","article-title":"Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome:Systematic review and meta-analysis","volume":"104","author":"Ford","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R98-20260409","doi-asserted-by":"crossref","first-page":"e0172846","DOI":"10.1371\/journal.pone.0172846","article-title":"Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome:A systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Zheng","year":"2017","journal-title":"PLoS One"},{"key":"R99-20260409","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/apt.17426","article-title":"Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea:The TRITON trial","volume":"57","author":"Gunn","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"R100-20260409","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/gutjnl-2018-318160","article-title":"Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern:Systematic review and network meta-analysis","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"key":"R101-20260409","doi-asserted-by":"crossref","first-page":"190","DOI":"10.14309\/ajg.0000000000000504","article-title":"Small intestinal bacterial overgrowth in irritable bowel syndrome:A systematic review and meta-analysis of case-control studies","volume":"115","author":"Shah","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R102-20260409","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/gut.2009.205476","article-title":"Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS","volume":"60","author":"Yu","year":"2011","journal-title":"Gut"},{"key":"R103-20260409","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"key":"R104-20260409","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"R105-20260409","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/apt.70420","article-title":"Clinical trial:Rifaximin versus low FODMAP diet in irritable bowel syndrome","volume":"63","author":"Chuah","year":"2026","journal-title":"Aliment Pharmacol Ther"},{"key":"R106-20260409","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/BF02212678","article-title":"Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity","volume":"40","author":"Trimble","year":"1995","journal-title":"Dig Dis Sci"},{"key":"R107-20260409","doi-asserted-by":"crossref","first-page":"a2313","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome:Systematic review and meta-analysis","volume":"337","author":"Ford","year":"2008","journal-title":"BMJ"},{"key":"R108-20260409","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/apt.17179","article-title":"Systematic review and meta-analysis:Efficacy of peppermint oil in irritable bowel syndrome","volume":"56","author":"Ingrosso","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"R109-20260409","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(00)70170-3","article-title":"Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention","volume":"118","author":"Mertz","year":"2000","journal-title":"Gastroenterology"},{"key":"R110-20260409","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1023\/A:1014729125428","article-title":"Evolution of visceral sensitivity in patients with irritable bowel syndrome","volume":"47","author":"Poitras","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R111-20260409","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction):A Rome foundation working team report","volume":"154","author":"Drossman","year":"2018","journal-title":"Gastroenterology"},{"key":"R112-20260409","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","article-title":"Effect of antidepressants and psychological therapies in irritable bowel syndrome:An updated systematic review and meta-analysis","volume":"114","author":"Ford","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R113-20260409","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2036.2008.03633.x","article-title":"Clinical trial:The effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome","volume":"27","author":"Vahedi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R114-20260409","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(23)01523-4","article-title":"Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS):A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Ford","year":"2023","journal-title":"Lancet"},{"key":"R115-20260409","first-page":"CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia","volume":"2","author":"Welsch","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R116-20260409","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41575-023-00794-z","article-title":"Irritable bowel syndrome and mental health comorbidity-approach to multidisciplinary management","volume":"20","author":"Staudacher","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R117-20260409","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/apt.15325","article-title":"Systematic review with meta-analysis:The prevalence of anxiety and depression in patients with irritable bowel syndrome","volume":"50","author":"Zamani","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R118-20260409","first-page":"1613","article-title":"Assessing telephone-delivered cognitive\u2013behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB):A multicentre randomised trial","volume":"68","author":"Everitt","year":"2019","journal-title":"Gut"},{"key":"R119-20260409","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2468-1253(19)30243-2","article-title":"Cognitive behavioural therapy for irritable bowel syndrome:24-month follow-up of participants in the ACTIB randomised trial","volume":"4","author":"Everitt","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R120-20260409","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/apt.16934","article-title":"Randomised clinical trial:Individual versus group hypnotherapy for irritable bowel syndrome","volume":"55","author":"L\u00f6vdahl","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"R121-20260409","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gutjnl-2020-321191","article-title":"Efficacy of psychological therapies for irritable bowel syndrome:Systematic review and network meta-analysis","volume":"69","author":"Black","year":"2020","journal-title":"Gut"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_472_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:45:53Z","timestamp":1787067953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_472_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":120,"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_472_25","relation":{},"ISSN":["1319-3767","1998-4049"],"issn-type":[{"value":"1319-3767","type":"print"},{"value":"1998-4049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"2025-12-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}